ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Ke Zhang
Matched on ORCID iD 0000-0003-2771-0080; OpenAlex author ID A5089630065. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2019: 2 papers · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper
Papers 5
- Plasma metabolites as mediators in immune cell-pancreatic cancer risk: insights from Mendelian randomization. Co-author DOI 10.3389/fimmu.2024.1402113↗
- Comprehensive analysis of expression profile and prognostic significance of interferon regulatory factors in pancreatic cancer. Co-author DOI 10.1186/s12863-021-01019-5↗
- Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma: a propensity score matching analysis. Co-author DOI 10.1186/s12885-020-07023-9↗
- A novel scoring system based on hemostatic parameters predicts the prognosis of patients with advanced pancreatic cancer. Co-author DOI 10.1016/j.pan.2018.12.010↗
- Systemic immune-inflammation index predicts prognosis of patients with advanced pancreatic cancer. Co-author DOI 10.1186/s12967-019-1782-x↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zhen Chen · 4 shared papers, 2019–2022 · strength 0.48
- Paper Comprehensive analysis of expression profile and prognostic significance of interferon regulatory factors in pancreatic… DOI 10.1186/s12863-021-01019-5↗
- Paper Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma… DOI 10.1186/s12885-020-07023-9↗
- Paper Systemic immune-inflammation index predicts prognosis of patients with advanced pancreatic cancer. DOI 10.1186/s12967-019-1782-x↗
- Lianyu Chen · 3 shared papers, 2019–2022 · strength 0.38
- Paper Comprehensive analysis of expression profile and prognostic significance of interferon regulatory factors in pancreatic… DOI 10.1186/s12863-021-01019-5↗
- Paper Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma… DOI 10.1186/s12885-020-07023-9↗
- Paper Systemic immune-inflammation index predicts prognosis of patients with advanced pancreatic cancer. DOI 10.1186/s12967-019-1782-x↗
- Shu Dong Ma · 2 shared papers, 2020–2022 · strength 0.28
- Paper Comprehensive analysis of expression profile and prognostic significance of interferon regulatory factors in pancreatic… DOI 10.1186/s12863-021-01019-5↗
- Paper Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma… DOI 10.1186/s12885-020-07023-9↗
- Hao Chen · 2 shared papers, 2019–2020 · strength 0.22
- Yong-Qiang Hua · 2 shared papers, 2019–2020 · strength 0.22
- Paper Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma… DOI 10.1186/s12885-020-07023-9↗
- Paper A novel scoring system based on hemostatic parameters predicts the prognosis of patients with advanced pancreatic cance… DOI 10.1016/j.pan.2018.12.010↗
- Hui-Feng Gao · 2 shared papers, 2019–2020 · strength 0.22
- Paper Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma… DOI 10.1186/s12885-020-07023-9↗
- Paper A novel scoring system based on hemostatic parameters predicts the prognosis of patients with advanced pancreatic cance… DOI 10.1016/j.pan.2018.12.010↗
- Xinyu Ge · 1 shared paper, 2024 · strength 0.20
- Jie Zhu · 1 shared paper, 2024 · strength 0.20
- Jie J. Yao · 1 shared paper, 2024 · strength 0.20
- Huifeng Gao · 1 shared paper, 2022 · strength 0.16
- Yujie Li · 1 shared paper, 2022 · strength 0.16
- Hao Chen · 1 shared paper, 2022 · strength 0.16
- Panling Xu · 1 shared paper, 2022 · strength 0.16
- Yongqiang Hua · 1 shared paper, 2019 · strength 0.10
- Luming Liu · 1 shared paper, 2019 · strength 0.10
- Lu-Ming Liu · 1 shared paper, 2019 · strength 0.10
- Hao Chen · 1 shared paper, 2019 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.